{
  "timestamp": "20250610_103713",
  "evaluation_duration": 270.08246302604675,
  "pipeline_results": {
    "BasicRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "[Document(page_content='67', metadata={}, id='2297'), Document(page_content='68', metadata={}, id='2458'), Document(page_content='87', metadata={}, id='3292'), Document(page_content='71', metadata={}, id='2915'), Document(page_content='76', metadata={}, id='2674')]",
        "contexts": [],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 0.14562678337097168,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "[Document(page_content='73', metadata={}, id='2624'), Document(page_content='73', metadata={}, id='2914'), Document(page_content='73', metadata={}, id='2759'), Document(page_content='73', metadata={}, id='3201'), Document(page_content='73', metadata={}, id='2875')]",
        "contexts": [],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 0.048422813415527344,
        "success": true,
        "error": null
      }
    ],
    "HyDERAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "Metformin is a commonly prescribed medication for the management of type 2 diabetes. Its primary effects include:\n\n1. **Lowering Blood Sugar Levels**: Metformin helps to reduce blood glucose levels by decreasing hepatic glucose production, particularly in the liver.\n\n2. **Improving Insulin Sensitivity**: It enhances the sensitivity of muscle cells to insulin, which helps the body use glucose more effectively.\n\n3. **Reducing Absorption of Glucose**: Metformin can decrease the absorption of glucose from the gastrointestinal tract, which contributes to lower blood sugar levels.\n\n4. **Weight Management**: Unlike some other diabetes medications, metformin is associated with weight neutrality or modest weight loss, making it a favorable option for overweight individuals with type 2 diabetes.\n\n5. **Cardiovascular Benefits**: Some studies suggest that metformin may have cardiovascular benefits, reducing the risk of heart disease in people with type 2 diabetes.\n\n6. **Potential Cancer Risk Reduction**: There is ongoing research into the potential of metformin to reduce the risk of certain types of cancer in diabetic patients.\n\nOverall, metformin is an effective first-line treatment for type 2 diabetes, helping to control blood sugar levels and improve overall metabolic health.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 60.53308892250061,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "SGLT2 (Sodium-Glucose Cotransporter 2) inhibition has several effects on kidney function, primarily beneficial in the context of diabetes and heart failure. Here are the key points regarding its impact:\n\n1. **Glucose Excretion**: SGLT2 inhibitors promote the excretion of glucose in the urine, which helps lower blood glucose levels. This is particularly beneficial for patients with type 2 diabetes.\n\n2. **Diuretic Effect**: By inhibiting SGLT2, these medications also have a mild diuretic effect, leading to increased urine output. This can help reduce fluid overload in patients with heart failure or chronic kidney disease.\n\n3. **Renal Hemodynamics**: SGLT2 inhibitors can improve renal hemodynamics by reducing intraglomerular pressure. This is achieved through the reduction of sodium reabsorption in the proximal tubule, which can lead to improved kidney function over time.\n\n4. **Cardiorenal Protection**: Studies have shown that SGLT2 inhibitors can provide protective effects on the kidneys, reducing the progression of diabetic kidney disease and lowering the risk of cardiovascular events.\n\n5. **Reduction in Albuminuria**: These medications have been associated with a reduction in albuminuria (the presence of albumin in urine), which is a marker of kidney damage.\n\nOverall, SGLT2 inhibitors are considered to have a protective role in kidney function, particularly in patients with diabetes and those at risk for cardiovascular and renal complications.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 99.3359580039978,
        "success": true,
        "error": null
      }
    ],
    "ColBERTRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 0.02618408203125,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 0.01693105697631836,
        "success": true,
        "error": null
      }
    ]
  },
  "ragas_results": {
    "BasicRAG": {
      "error": "No valid answers found",
      "answer_relevancy": null,
      "context_precision": null,
      "context_recall": null,
      "faithfulness": null,
      "answer_similarity": null,
      "answer_correctness": null
    },
    "HyDERAG": {
      "answer_relevancy": 0.9124517201700189,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "faithfulness": 0.5,
      "answer_similarity": null,
      "answer_correctness": 0.4352759671959121
    },
    "ColBERTRAG": {
      "error": "No valid answers found",
      "answer_relevancy": null,
      "context_precision": null,
      "context_recall": null,
      "faithfulness": null,
      "answer_similarity": null,
      "answer_correctness": null
    }
  }
}